Dr. Charles Lowenstein will be stepping down as director of the Division of Cardiology to become director of the Genetic Cardiovascular Risk Clinic.
We are grateful to Charlie for his leadership since 2020, during which time the Division of Cardiology has flourished. The Division has significantly expanded its clinical footprint, increasing outpatient visits, specialty procedures, and strengthening multidisciplinary programs across a wide range of cardiology subspecialties. Collaborative efforts across the Division, Department, and institution have grown, supporting strong alignment in clinical care, research, and education. The Division’s research enterprise has reached record levels of grant funding, including major network and national consortium awards. Its training programs continue to excel, supported by one of the longest-running T32 grants and an unprecedented number of career development awards for trainees and early‑career faculty.
Charlie came to Hopkins in 1991 as a cardiology fellow and joined the faculty in 1993, when he cared for patients in the Cardiac Care Unit and explored vascular biology pathways in the lab. He was the inaugural Clarence Doodeman Professor in Cardiology. In 2009, he left to lead the Cardiology Division at the University of Rochester. He returned to Hopkins in 2020 as director of the Division of Cardiology and co-director of the Heart & Vascular Institute. Charlie will lead the new Genetic Cardiovascular Risk Clinic while returning to the roles that originally brought him to Hopkins—non‑invasive cardiology and genetic research. We wish him great success as he embarks on this next chapter.
The Cardiology Division has thrived under Charlie’s leadership with the support, energy, and creativity of outstanding faculty, trainees, nurses, and staff – and it will continue to thrive in the future. A search for the next Director of the Division of Cardiology will be forthcoming.
